Medical News

RSS

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Novavax, Inc. announced today that it has received a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant from the NIAID is to support a segment of the Company's preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Scientists identify the first genetic mechanism that generates the cerebral cortex

The cerebral cortex, the largest and most complex component of the brain, is unique to mammals and alone has evolved human specializations. Although at first all stem cells in charge of building the cerebral cortex-the outermost layer of neurons commonly referred to as gray matter-are created equal, soon they irrevocably commit to forming specific cortical regions. But how the stem cells' destiny is determined has remained an open question.

14 Oct 2009

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

H1N1 patients with ARDS survive illness when treated with ECMO

Despite the severity of disease and the intensity of treatment, most patients in Australia and New Zealand who experienced respiratory failure as a result of 2009 influenza A(H1N1) and were treated with a system that adds oxygen to the patient's blood survived the disease, according to a study to appear in the November 4 issue of JAMA.

14 Oct 2009

Shire settles pending ADDERALL XR litigation with Sandoz

Shire plc, the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviated New Drug Application ("ANDA") and its attempt to market generic versions of Shire's ADDERALL XR(R) (mixed amphetamine salts) for the treatment of Attention Deficit Hyperactivity Disorder.

14 Oct 2009

Statewide H1N1 Vaccine Provider Registration System from Upp Technology

Supporting directives from the U.S. Centers for Disease Control and Prevention, Upp Software, a business unit of Upp Technology, Inc., has developed, delivered and now offers a Statewide H1N1 Vaccine Provider Registration System to accommodate thousands of vaccine providers' ordering and reporting needs.

14 Oct 2009

Advertisements can affect women's eating behaviors and intentions to diet and exercise

Overweight women's self-esteem plummets when they view photographs of models of any size, according to a new study in Journal of Consumer Research. And underweight women's esteem increases, regardless of models' size.

14 Oct 2009

Invacare Corporation's initiative to raise awareness of Chronic Obstructive Pulmonary Disease

Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City’s Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

Researchers to investigate an existing drug for speedy recovery of stroke patients

New research will determine whether an inexpensive drug called L-dopa, widely used in the treatment of Parkinson's disease, could also help thousands of stroke patients regain mobility and independence.

14 Oct 2009

States have initiated tort reform experiments

President Barack Obama can look to a variety of models as he seeks to fulfill a pledge to fund state tort reform experiments, a longtime wish-list item for physicians, the New York Times reports. States have so far tried a few approaches, with mixed results, and considered more.

14 Oct 2009

Portico Healthnet to launch Minnesota Coalition for Kids Health Coverage

Portico Healthnet, a non-profit agency working to reduce the number of people without coverage for health care services, has been awarded more than $988,000 by the U.S. Department of Health and Human Services (HHS) to launch the Minnesota Coalition for Kids Health Coverage, a partnership of community agencies from around the state, to identify and enroll uninsured children into the Medical Assistance and MinnesotaCare state health coverage safety net programs.

14 Oct 2009

CAHI releases statement on Senate health care reform proposal

Critics are up in arms over America's Health Insurance Plans (AHIP) daring to speak the truth about the Senate health care reform proposal, and we applaud the organization's efforts. If anything AHIP's analysis of health premium increases is too low. Supporters of the health bills are simply ignoring years of states' evidence of many of these proposed Senate and House health reforms.

14 Oct 2009

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to fund vaccine research associated with “Innate Immune Receptors and Adjuvant Discovery.” NanoBio is the principal subcontractor for the $9.3 million contract awarded to the University of Michigan.

14 Oct 2009

Bicycle-related injuries on the rise

Record-high gasoline prices, the slowdown in the economy, and increasing environmental sensitivity are leading more people to bike to work or for play. But an adequate infrastructure may not be in place to protect cyclists from serious injury according to surgeons who presented a new study on the issue during a scientific paper session at the 2009 Clinical Congress of the American College of Surgeons.

14 Oct 2009

Decision Resources: Rheumatoid arthritis drug market in India to grow up to $672 million in 2013

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.

14 Oct 2009

Catalyst Health Solutions enters into an amended agreement with Wachovia Bank to extend its credit facility

Catalyst Health Solutions, Inc., a pharmacy benefit management (PBM) company, announced today that it has entered into an amended agreement with Wachovia Bank, N.A., a Wells Fargo Company, to extend and increase its secured revolving credit facility. The new credit facility will mature on October 9, 2012 and has been increased from $50 million to $100 million.

14 Oct 2009

Luminous Medical to incorporate glucose sensor in its automated blood glucose monitor

Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous' automated blood glucose monitor.

14 Oct 2009

Finance Democrats approve overhaul measure with boost from Snowe

The Senate Finance Committee approved its long-anticipated version of the health-care overhaul legislation in a 14-9 vote Tuesday, the Wall Street Journal reports. Sen. Olympia Snowe, R-Maine, joined the panels 13 Democrats to support the bill.

14 Oct 2009

Medical News

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Scientists identify the first genetic mechanism that generates the cerebral cortex

American Recovery and Reinvestment Act funds to support research in numerous health areas

H1N1 patients with ARDS survive illness when treated with ECMO

Shire settles pending ADDERALL XR litigation with Sandoz

Statewide H1N1 Vaccine Provider Registration System from Upp Technology

Advertisements can affect women's eating behaviors and intentions to diet and exercise

Invacare Corporation's initiative to raise awareness of Chronic Obstructive Pulmonary Disease

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Researchers to investigate an existing drug for speedy recovery of stroke patients

States have initiated tort reform experiments

Portico Healthnet to launch Minnesota Coalition for Kids Health Coverage

CAHI releases statement on Senate health care reform proposal

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

Bicycle-related injuries on the rise

Decision Resources: Rheumatoid arthritis drug market in India to grow up to $672 million in 2013

Catalyst Health Solutions enters into an amended agreement with Wachovia Bank to extend its credit facility

Luminous Medical to incorporate glucose sensor in its automated blood glucose monitor

Finance Democrats approve overhaul measure with boost from Snowe

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News